StockData
PHGNYSEX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31Also trades as RYLPF

KONINKLIJKE PHILIPS NV

Financials through fiscal 2024, year ended Dec 31, 2025Last filing: 20-F on Feb 19, 2026
$25.50−0.24 (-0.93%)

Close on Oct 19, 2026

About Koninklijke Philips

X-Ray Apparatus & Tubes & Related Irradiation Apparatus, SIC 3844

The provided document consists of raw XBRL taxonomy tags and financial reporting segments rather than narrative business disclosures. Based strictly on the identified operating segments, the enterprise organizes its operations across Diagnosis & Treatment, Connected Care, and Personal Health divisions, with additional corporate activities categorized under Other. These divisions indicate activities spanning diagnostic imaging and therapeutic solutions, patient monitoring and healthcare connectivity systems, and personal health consumer appliances. The reporting tags do not state the identity or nature of its end customers.

Geographic segmentation tags within the text reference operations across Western Europe, North America, mature geographies, and growth markets, with specific country mentions including the Netherlands, the United States, China, Japan, and Germany. The provided filing text does not disclose operational figures such as facility counts or store numbers, nor does it identify the company's headquarters location.

Summary of the business section of Koninklijke Philips's latest annual report, written by StockData.

Company profile

Company

Legal name
KONINKLIJKE PHILIPS NV
Founded
1891
Headquarters
Amsterdam, Netherlands
Address
Prinses Irenestraat 59 1077WV
Phone
31 20 59 77777
Employees
24,544, Dec 31, 2024
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Incorporated in
P7
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers Accountants N.V., Amsterdam, The Netherlands

Stock & identifiers

Ticker
PHG
Other tickers
RYLPF
Exchange
NYSE
Shares outstanding
963M, Dec 31, 2025
Filer category
Large accelerated filer
Stock splits
4-for-1, Apr 18, 2000
SEC CIK
313216
CUSIP
500472303
ISIN
US5004723038
LEI
H1FJE8H61JGM1JSGM897
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Koninklijke Philips's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“At year-end 2024, Diagnosis & Treatment had 24,544 employees worldwide.”

Corporate history

Events identified from SEC filings

DateEventDetails
Dec 23, 2020Tender offerThird-party tender offer for the company's shares
Jul 12, 2017Tender offerThird-party tender offer for the company's shares
Dec 30, 2014Tender offerThird-party tender offer for the company's shares
May 6, 2013Name changeName changed from KONINKLIJKE PHILIPS ELECTRONICS NV to KONINKLIJKE PHILIPS NV
Jan 3, 2008Tender offerThird-party tender offer for the company's shares
Nov 30, 2007Tender offerThird-party tender offer for the company's shares
Nov 14, 2000Tender offerThird-party tender offer for the company's shares
Jun 1, 2000Tender offerThird-party tender offer for the company's shares
Aug 31, 1998Name changeName changed from PHILIPS ELECTRONICS N V to KONINKLIJKE PHILIPS ELECTRONICS NV